United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0054-3630_ce07dc5c-441e-4f1c-a940-077306017c43
- Product NDC
- 0054-3630
- Form
- SUSPENSION
- Composition / generic term
- Naproxen
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210224
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 125 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 500 mL in 1 BOTTLE, PLASTIC (0054-3630-63) · 0054-3630-63
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →